Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
CD163 overexpression
i
Other names:
CD163, CD163 Molecule, M130, Scavenger Receptor Cysteine-Rich Type 1 Protein M130, Hemoglobin Scavenger Receptor, CD163 Antigen, SCARI1, MM130, Macrophage-Associated Antigen
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
9332
Related biomarkers:
Expression
Others
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
CD163 overexpression
Hodgkin Lymphoma
CD163 overexpression
Hodgkin Lymphoma
nivolumab + brentuximab vedotin
Sensitive: C3 – Early Trials
nivolumab + brentuximab vedotin
Sensitive
:
C3
nivolumab + brentuximab vedotin
Sensitive: C3 – Early Trials
nivolumab + brentuximab vedotin
Sensitive
:
C3
CD163 overexpression
Solid Tumor
CD163 overexpression
Solid Tumor
avelumab + eftilagimod alpha
Sensitive: C3 – Early Trials
avelumab + eftilagimod alpha
Sensitive
:
C3
avelumab + eftilagimod alpha
Sensitive: C3 – Early Trials
avelumab + eftilagimod alpha
Sensitive
:
C3
CD163 overexpression
Solid Tumor
CD163 overexpression
Solid Tumor
eftilagimod alpha
Sensitive: C3 – Early Trials
eftilagimod alpha
Sensitive
:
C3
eftilagimod alpha
Sensitive: C3 – Early Trials
eftilagimod alpha
Sensitive
:
C3
CD163 overexpression
Bladder Cancer
CD163 overexpression
Bladder Cancer
pembrolizumab
Sensitive: C3 – Early Trials
pembrolizumab
Sensitive
:
C3
pembrolizumab
Sensitive: C3 – Early Trials
pembrolizumab
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login